Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The news

The news

posted on Apr 15, 2008 01:00PM
President and CEO Rick Goerner, said, We are announcing a resumption of the companys open market share repurchase program, which will take advantage of attractive price point opportunities to buy back company stock. We also believe the specific issues that initiated the trading restriction for the companys directors, officers, employees and consultants who have knowledge of the terms surrounding the December 2007 settlements have been addressed with the public disclosures of last week.

 


Share
New Message
Please login to post a reply